PerkinElmer to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PerkinElmer Inc., (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023 at 2:15 p.m. ET.

Steve Willoughby, senior vice president, investor relations & head of ESG, and Alan Fletcher, senior vice president, Life Sciences, will provide an update on the Company and its strategic priorities. To register, click here.

A live audio webcast will be available on the Events section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer Investor Relations website after the event and will be available for at least 30 days.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $4.6 billion in 2022, has more than 16,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available at www.perkinelmer.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  225.29
-5.01 (-2.18%)
AAPL  271.41
+1.71 (0.63%)
AMD  260.04
-4.29 (-1.62%)
BAC  53.08
+0.50 (0.94%)
GOOG  283.89
+8.72 (3.17%)
META  665.72
-85.95 (-11.44%)
MSFT  523.29
-18.26 (-3.37%)
NVDA  203.18
-3.86 (-1.86%)
ORCL  260.88
-14.42 (-5.24%)
TSLA  443.48
-18.03 (-3.91%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.